BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23203126)

  • 1. Clinicopathological significance of NMIIA overexpression in human gastric cancer.
    Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
    Int J Mol Sci; 2012 Nov; 13(11):15291-304. PubMed ID: 23203126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
    Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
    Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
    Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
    PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
    Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
    Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer.
    Liang S; He L; Zhao X; Miao Y; Gu Y; Guo C; Xue Z; Dou W; Hu F; Wu K; Nie Y; Fan D
    PLoS One; 2011 Apr; 6(4):e18409. PubMed ID: 21533124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
    Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
    World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
    Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
    J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of non‑muscle myosin IIA expression inhibits migration and invasion of gastric cancer cells via the c‑Jun N‑terminal kinase signaling pathway.
    Liu T; Ye Y; Zhang X; Zhu A; Yang Z; Fu Y; Wei C; Liu Q; Zhao C; Wang G
    Mol Med Rep; 2016 Feb; 13(2):1639-44. PubMed ID: 26719067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
    Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
    Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
    Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
    Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.